Multiple Sclerosis
Advances in Clinical Trial Design, Treatment and Future Perspectives
Published on 1. October 1996
Book
Hardback
XVIII, 364 pages
978-3-540-76018-4 (ISBN)
Description
This book reviews the therapeutic developments in clinical trial design that have resulted in new treatment options for patients suffering from MS. Important ethical considerations that arise with the new treatments are included, as well as the perspective on the emergence of MS as a treatable disease.
More details
Edition
1st Edition.
Language
English
Place of publication
London
United Kingdom
Publishing group
Springer Berlin
Target group
College/higher education
Professional and scholarly
Research
Illustrations
4 s/w Abbildungen
illustrations
Dimensions
Height: 240 mm
Weight
690 gr
ISBN-13
978-3-540-76018-4 (9783540760184)
DOI
10.1007/978-1-4471-1271-6
Schweitzer Classification
Other editions
Additional editions
Donald E. Goodkin | Richard A. Rudick
Multiple Sclerosis
Advances in Clinical Trial Design, Treatment and Future Perspectives
E-Book
12/2012
Springer
€96.29
Available for download
Donald E. Goodkin | Richard A. Rudick
Multiple Sclerosis
Advances in Clinical Trial Design, Treatment and Future Perspectives
Book
05/1998
Springer
€106.99
Shipment within 15-20 days
Content
1 Recent Advances and Future Challenges in Multiple Sclerosis Clinical Trial Design.- 2 Pathogenesis of Multiple Sclerosis: Relationship to Therapeutic Strategies.- 3 Future of Multiple Sclerosis Therapeutics: Rational Approaches Targeting Putative Pathogenic Mechanisms.- 4 Statistical and Design Considerations for Multiple Sclerosis Clinical Trials.- 5 Clinical Outcome Measures for Multiple Sclerosis.- 6 Use of Neuropsychologic Outcome Measures in Multiple Sclerosis Clinical Trials: Current Status and Strategies for Improving Multiple Sclerosis Clinical Trial Design.- 7 "Quality of Life" Assessment in Multiple Sclerosis Clinical Trials: Current Status and Strategies for Improving Multiple Sclerosis Clinical Trial Design.- 8. Magnetic Resonance Imaging: Current Status and Strategies for Improving Multiple Sclerosis Clinical Trial Design.- 9. Magnetic Resonance Imaging of Patients with Isolated Idiopathic Optic Neuritis, Brainstem Syndromes and Myelopathy.- 10 Strategies to Delay the Onset of Clinically Definite Multiple Sclerosis in Patients with Monosymptomatic Presentations of Optic Neuritis, Brainstem Syndromes or Myelopathy.- 11 Treatment of Multiple Sclerosis with Type I Interferons.- 12 Treatment of Multiple Sclerosis with Methotrexate.- 13 Treatment of Multiple Sclerosis with Copolymer 1.- 14 Treatment of Multiple Sclerosis with Cladribine.- 15 Ethical Considerations Raised by Clinical Trials.- 16 The Emergence of Multiple Sclerosis as a "Treatable" Condition: An Historical Perspective.